White Paper

Scalability, Quality, and Speed with Transposons

Format: PDF file | Document type: White Paper | Promoted Content

This content is provided by Wheeler Bio, and any views and opinions expressed do not necessarily reflect those of www.biopharma-reporter.com

Scalability, Quality, and Speed with Transposons

To solve for the significant bottlenecks often presented by conventional cell line development processes, this article discusses how Wheeler Bio is leveraging transposon-based gene delivery to compress timelines, increase clone stability, and offer uncompromising titers. As an integral enabler of our innovative Portable CMC™ Clone Selection service, this cutting-edge approach is a key differentiator to our CLD services.

Related resources from Wheeler Bio

Supplier info centre